David Higgins

Dr. David Higgins

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
DHDavid Higgins
David Higgins
SOSean T. O’Leary
Sean T. O’Leary
The worldwide elimination of measles and rubella is feasible, but not without overcoming the substantial challenge of vaccine hesitancy. This challenge is complicated by the spread of misinformation and disinformation fueled by rapidly progressing technologies and evolving forms of online communication. The recent COVID-19 pandemic has only added further complexity to this challenge. However, considerable progress has been made in understanding the scope of the problem and the complex factors that influence vaccine hesitancy. Our understanding of evidence-based strategies for addressing vaccine hesitancy has grown significantly, including evidence for effective communication and behavioral interventions. In this article, we review measles and rubella vaccines and vaccine hesitancy. We then provide an overview of evidence-based strategies for addressing vaccine hesitancy, including communication strategies and behavioral interventions. This article is relevant to healthcare professionals, health system leaders, public health professionals, policymakers, community leaders, and any individuals who have a role in addressing vaccine hesitancy in their communities. Finally, we review future directions and major areas of research need.

9 February 2023 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
DHDavid Higgins
David Higgins
MMMaShawn Moore
MaShawn Moore
LALucy Alderton
Lucy Alderton
LWLaura Weinberg
Laura Weinberg
AHAndrew M Hickok
Andrew M Hickok
KWKaren A Wendel
Karen A Wendel
Background: Innovative approaches such as online, at-home programs may address important barriers to sexually transmitted infection (STI) and human immunodeficiency virus (HIV) screening in the United States. This study evaluated the first year of an online, at-home program offering HIV and triple-site (urogenital, rectal, and pharyngeal) gonorrhea (GC) and chlamydia (CT) testing in Colorado. Methods: Test Yourself Colorado (TYC) is an online, at-home program that provides free mailed HIV tests and/or GC/CT tests to Colorado adults. Program use and outcomes between 1 June 2021 and 31 May 2022 were analyzed. Results: A total of 1790 unique clients utilized TYC. Of 1709 clients who ordered HIV tests, 508 (29.7%) were men who have sex with men (MSM), and 41.3% (210/508) of these clients reported having never been tested for HIV before or were not tested in the prior year. Hispanic clients had lower STI test return rates (37.1%; 134/361) compared with non-Hispanic clients (45.9%; 518/1128) (P = .003). Positive STI tests were identified in 9.6% (68/708) of clients. Positive STI tests were more common in MSM clients (15.7%; 34/216) compared with all other sexual orientations (6.9%; 34/492) (P < .001). STI treatment was confirmed in 80.9% (55/68) of clients. Conclusions: The TYC online, home testing portal is a scalable tool that reaches clients at risk of STIs and HIV and navigates those with positive STI tests to treatment. HIV/STI home testing programs need to further assess and address utilization and outcomes for disparities by race and ethnicity to assure programs equitably benefit all at-risk communities.

8 June 2023 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
DHDavid Higgins
David Higgins
AHAllison L. Haynes
Allison L. Haynes
JJJulia C. Jensen
Julia C. Jensen
SOSean T. O’Leary
Sean T. O’Leary
AMAngela Moss
Angela Moss
NCNed Calonge
Ned Calonge
Background: The hepatitis B vaccine (HBV) is recommended at birth to prevent perinatal hepatitis B transmission; however, many newborns still do not receive HBV. The extent to which planned out-of-hospital births, which have increased over the past decade, are associated with nonreceipt of the HBV birth dose is unknown. The purpose of this study was to determine whether a planned out-of-hospital birth location is associated with the nonreceipt of the HBV birth dose. Methods: We performed a retrospective cohort study of all births from 2007 to 2019 recorded in the Colorado birth registry. χ 2 analyses were used to compare maternal demographics by birth location. Univariate and multiple logistic regression were used to evaluate the association of birth location with nonreceipt of the HBV birth dose. Results: In total 1.5% of neonates born in freestanding birth centers and 0.1% of neonates born at a planned home birth received HBV compared to 76.3% of neonates born in a hospital location. After adjusting for confounders, this translated to a large increase in the odds of not receiving HBV compared to in-hospital births [freestanding birth center (aodds ratio (aOR): 172.98, 95% confidence interval (CI): 136.98–219.88); planned home birth (aOR: 502.05, 95% CI: 363.04–694.29)]. Additionally, older maternal age, White/non-Hispanic race and ethnicity, higher income, and private or no insurance were associated with nonreceipt of the HBV birth dose. Conclusions: Planned out-of-hospital birth is a risk factor for nonreceipt of the HBV birth dose. As births in these locations become more common, targeted policies and education are warranted.

8 April 2025 in Academic Pediatrics
Verified
Journal Article
Closed access
DHDavid Higgins
David Higgins
MBMersine A. Bryan
Mersine A. Bryan
SOSean T. O’Leary
Sean T. O’Leary
DODouglas J. Opel
Douglas J. Opel

1 October 2024 in American Journal of Public Health
Verified
Journal Article
Closed access
DHDavid Higgins
David Higgins
SOSean T. O’leary
Sean T. O’leary

18 October 2023 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
DHDavid Higgins
David Higgins
SOSean T. O'LEary
Sean T. O'LEary